Related Articles
Non‑alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review)
Abnormal metabolic processes involved in the pathogenesis of non‑alcoholic fatty liver disease (Review)
Fatty acids and their role in type‑2 diabetes (Review)
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)
Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review)